THE PENNANT GROUP, INC. (PNTG) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $5.00M; Long-term DebtUSD $192.50M; Long-term Debt, GrossUSD $198.50M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $5.00M; Long-term DebtUSD $164.67M; Long-term Debt, GrossUSD $170.75M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $5.00M; Long-term DebtUSD $168.84M; Long-term Debt, GrossUSD $175.00M; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD (m).
- 2025-09-30: Long-term Debt, Current MaturitiesUSD (m); Long-term DebtUSD $26.00M; Long-term Debt, GrossUSD (m); Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, NetUSD $3.26M.
THE PENNANT GROUP, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt USD | Long-term Debt, Gross USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Line of Credit Facility, Maximum Borrowing Capacity USD |
|---|---|---|---|---|---|
| 2026-06-30 | $5.00M | $192.50M | $198.50M | (m) | (m) |
| 2026-03-31 | $5.00M | $164.67M | $170.75M | (m) | (m) |
| 2025-12-31 | $5.00M | $168.84M | $175.00M | (m) | (m) |
| 2025-09-30 | (m) | $26.00M | (m) | $3.26M | (m) |
| 2025-06-30 | (m) | $37.00M | (m) | $3.47M | (m) |
| 2025-03-31 | (m) | $52.50M | (m) | $3.70M | (m) |
| 2024-12-31 | $0.00 | $0.00 | $0.00 | (m) | (m) |
| 2024-12-31 | (m) | (m) | (m) | $3.91M | (m) |
| 2024-09-30 | (m) | $108.88M | (m) | (m) | (m) |
| 2024-06-30 | (m) | $82.17M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $83.29M | (m) | (m) | (m) |
| 2023-12-31 | (m) | $63.91M | (m) | (m) | (m) |
| 2023-09-30 | (m) | $53.78M | (m) | (m) | (m) |
| 2023-06-30 | (m) | $59.15M | (m) | (m) | (m) |
| 2023-03-31 | (m) | $57.02M | (m) | (m) | (m) |
| 2022-12-31 | (m) | $62.89M | (m) | (m) | (m) |
| 2022-09-30 | (m) | $55.76M | (m) | (m) | (m) |
| 2022-06-30 | (m) | $53.13M | (m) | (m) | (m) |
| 2022-03-31 | (m) | $56.50M | (m) | (m) | (m) |
| 2021-12-31 | (m) | $51.37M | (m) | (m) | (m) |
| 2021-09-30 | (m) | $42.74M | (m) | (m) | (m) |
| 2021-06-30 | (m) | $38.11M | (m) | (m) | (m) |
| 2021-03-31 | (m) | $24.97M | (m) | (m) | (m) |
| 2021-02-23 | (m) | (m) | (m) | (m) | $150.00M |
| 2020-12-31 | (m) | $8.28M | (m) | (m) | (m) |
| 2020-09-30 | (m) | $696.00K | (m) | (m) | (m) |
| 2020-06-30 | (m) | $642.00K | (m) | (m) | (m) |
| 2020-03-31 | (m) | $27.56M | (m) | (m) | (m) |
| 2019-12-31 | (m) | $18.53M | (m) | (m) | (m) |
| 2018-12-31 | (m) | $0.00 | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |